EUVIMEDEUVIMED entdecken
Fallbericht

Syndrome de Cushing sous fluticasone inhalée : interactions médicamenteuses à éviter

M Briard, C Godet, D Mouren, G Weisenburger, H Mal, J Messika, M Salpin, T Goletto, V Bunel, M Veyrier

Revue des Maladies Respiratoires · 2023

DOI: 10.1016/j.rmr.2023.07.005 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Revue des Maladies Respiratoires, 2023. Verfasst von M Briard und 9 weiteren Autor:innen. Beteiligte Einrichtung: AP-HP Nord-Université Paris-Cité, hôpital Bichat-Claude Bernard, service de pharmacie, 75018 Paris, France. Electronic address: mathilde.briard@aphp.…. Hauptthemen laut MEDLINE: Cushing Syndrome. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 7 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cushing's syndrome is an iatrogenic event occurring during co-administration of inhaled corticosteroids and potent inhibitors of P450 cytochromes. We report the clinical case of a 29-year-old woman with a past history of asthma treated with inhaled fluticasone propionate (FP), chronic pulmonary aspergillosis and allergic bronchopulmonary aspergillosis (ABPA) treated with itraconazole (ITZ), and Mycobacterium xenopi infection treated with moxifloxacin (MXF), ethambutol (EMB) and clarithromycin (CLR). Four months after initiation of antibiotic and antifungal medication, the patient contracted Cushing's syndrome. Its etiology consisted in interaction between FP, ITZ and CLR, which led to pronouncedly increased corticosteroid concentrations in circulating plasma cells. Following on the one hand cessation of FP and ITZ and on the other hand hydrocortisone supplementation, evolution was favorable. Several cases of iatrogenic Cushing's syndrome induced by co-administration of FP and potent CYP3A4 inhibitors have been reported in the literature. If possible, FP should be avoided in patients being treated with CYP3A4 inhibitors. Due to its differing physicochemical properties, beclometasone may be considered as the safest therapeutic alternative.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cushing SyndromeFemaleHumansAdultCytochrome P-450 CYP3A InhibitorsAndrostadienesFluticasoneAdrenal Cortex HormonesDrug InteractionsClarithromycinIatrogenic Disease

Stichwörter der Autor:innen

Corticoïde inhaléCushing's syndromeCytochrome p450Drug interactionsInhaled corticosteroidsInteraction médicamenteuseSyndrome de Cushing

Substanzen

Cytochrome P-450 CYP3A InhibitorsAndrostadienesFluticasoneAdrenal Cortex HormonesClarithromycin

Autor:innen und Institutionen

  • AP-HP Nord-Université Paris-Cité, hôpital Bichat-Claude Bernard, service de pharmacie, 75018 Paris, France. Electronic address: mathilde.briard@aphp.fr.
  • AP-HP Nord-Université Paris-Cité, hôpital Bichat-Claude Bernard, service de pneumologie B et transplantation pulmonaire, Paris, France; Physiopathology and Epidemiology of Respiratory Diseases, UMR1152 INSERM and Univer…
  • AP-HP Nord-Université Paris-Cité, hôpital Bichat-Claude Bernard, service de pneumologie B et transplantation pulmonaire, Paris, France.
  • AP-HP Nord-Université Paris-Cité, hôpital Bichat-Claude Bernard, service de pharmacie, 75018 Paris, France.

Zitieren

APA

Briard, M., Godet, C., Mouren, D., Weisenburger, G., Mal, H., Messika, J., Salpin, M., Goletto, T., Bunel, V., & Veyrier, M. (2023). Syndrome de Cushing sous fluticasone inhalée : interactions médicamenteuses à éviter. Revue des Maladies Respiratoires. https://doi.org/10.1016/j.rmr.2023.07.005

Vancouver

Briard M, Godet C, Mouren D, Weisenburger G, Mal H, Messika J, et al. Syndrome de Cushing sous fluticasone inhalée : interactions médicamenteuses à éviter. Revue des Maladies Respiratoires. 2023. doi:10.1016/j.rmr.2023.07.005

BibTeX
@article{Briard2023,
  author = {Briard, M and Godet, C and Mouren, D and Weisenburger, G and Mal, H and Messika, J and Salpin, M and Goletto, T and Bunel, V and Veyrier, M},
  title = {Syndrome de Cushing sous fluticasone inhalée : interactions médicamenteuses à éviter},
  journal = {Revue des Maladies Respiratoires},
  year = {2023},
  doi = {10.1016/j.rmr.2023.07.005}
}
Kostenlos starten →